Charles S. Fuchs

Active 1988–2025

Also published as
Charles S Fuchs
435
Papers
101,344
Citations
171
h-index
432
i10-index

Citations

Citations per year for Charles S. Fuchs1939: 1 citations1948: 2 citations1990: 2 citations1991: 3 citations1992: 7 citations1993: 63 citations1994: 57 citations1995: 58 citations1996: 65 citations1997: 61 citations1998: 66 citations1999: 104 citations2000: 117 citations2001: 119 citations2002: 137 citations2003: 147 citations2004: 197 citations2005: 286 citations2006: 340 citations2007: 485 citations2008: 619 citations2009: 812 citations2010: 1,020 citations2011: 890 citations2012: 882 citations2013: 1,058 citations2014: 1,019 citations2015: 1,106 citations2016: 1,144 citations2017: 1,135 citations2018: 1,274 citations2019: 3,724 citations2020: 4,000 citations2021: 3,768 citations2022: 3,124 citations2023: 2,365 citations2024: 3,109 citations2025: 1,596 citations2026: 39 citations1940–1947: no citations, so these years are not shown1949–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,277 citing papers, 26.1% of this breakdownChina: 5,279 citing papers, 13.4% of this breakdownUnited Kingdom: 2,261 citing papers, 5.7% of this breakdownItaly: 1,809 citing papers, 4.6% of this breakdownGermany: 1,740 citing papers, 4.4% of this breakdownJapan: 1,366 citing papers, 3.5% of this breakdownCanada: 1,308 citing papers, 3.3% of this breakdownFrance: 1,283 citing papers, 3.3% of this breakdownSpain: 1,125 citing papers, 2.9% of this breakdownAustralia: 1,013 citing papers, 2.6% of this breakdownNetherlands: 1,013 citing papers, 2.6% of this breakdownSouth Korea: 947 citing papers, 2.4% of this breakdown
0%26.1%Other 25.2%

Fields

  • Medicine62.8%
  • Biochemistry, Genetics and Molecular Biology27.4%
  • Immunology and Microbiology2.4%
  • Neuroscience1.3%
  • Nursing1.3%
  • Dentistry0.9%
  • Other3.9%

Topics

  • Cancer Immunotherapy and Biomarkers3.4%
  • Gut microbiota and health3.2%
  • Colorectal Cancer Screening and Detection2.9%
  • Colorectal Cancer Treatments and Studies2.8%
  • Genetic factors in colorectal cancer2.7%
  • Pancreatic and Hepatic Oncology Research2.6%
  • Other82.4%

Coauthors

All papers

Open in search
  1. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

    Authors: , , , , , , , , , , , , , , - Cell Host & Microbe 2013 cited by 2,719

  2. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2017 cited by 1,563

  3. Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 1,125

  4. Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 cited by 1,812

  5. Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2015 cited by 1,074

  6. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean–Luc Van Laethem, Eric Van Cutsem, Scott Berry, Mark Vincent, Bettina Müller, Felipe Rey, Ángela R. Zambrano, Joaquín Guerra, Merete Krogh, Lene Bæksgaard, Mette Yilmaz, Anneli Elme, Andrus Magi, Päivi Auvinen, Tuomo Alanko, Markus Moehler, Volker Kunzmann, Thomas Seufferlein, Peter Thuss-Patience, Eray Goekkurt, Thomas Hoehler, Georg Martin Haag, Salah‐Eddin Al‐Batran, Hugo R. Castro, Karla Alejandra Lopez, Mynor Aguilar Vasquez, Mario Sandoval, Ka On Lam, Sinéad Cuffe, Cathy Kelly, Ravit Geva, Einat Shacham‐Shmueli, Ayala Hubert, Alex Beny, Baruch Brenner, Giuseppe Aprile, Alfredo Falcone, Evaristo Maiello, Rodolfo Passalacqua, Vincenzo Montesarchio, Hiroki Hara, Keisho Chìn, Tomohiro Nishina, Yoshito Komatsu, Nozumo Machida, Shuichi Hironaka, Taroh Satoh, Takao Tamura, Naotaoshi Sugimoto, Haruhiko Cho, Yashushi Omuro, Ken Kato, Masahiro Goto, Ichinosuke Hyodo, Kazuhiro Yoshida, Hideo Baba, Taito Esaki, Junji Furuse, Wan Zamaniah Wan Mohammed, Carlos Hernández Hernández, Juan Casas Garcia, Adriana Dominguez Andrade, Katriona Clarke, Geir Olav Hjortland, Nils Glenjen, Tomasz Kubiatowski, Jassem Jacek, Marek Z. Wojtukiewicz, Sergey Lazarev, Yuri Lancukhay and 58 more - The Lancet 2018 cited by 1,316

  7. Fusobacterium nucleatumand T Cells in Colorectal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2015 cited by 661

  8. Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 443

  9. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2013 cited by 2,200

  10. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2016 cited by 930

  11. Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,484

  12. Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women

    Authors: , , , , , , , , , , , , - JAMA Oncology 2018 cited by 522

  13. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise

    Authors: , , , - The Oncologist 2016 cited by 797

  14. A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis

    Authors: , , , , , , , , , - Gastroenterology 2013 cited by 631

  15. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas J. Wang, Robert E. Gerszten, Charles S. Fuchs, Matthew G. Vander Heiden, Brian M. Wolpin - Nature Medicine 2014 cited by 662

  16. Genetic Mechanisms of Immune Evasion in Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen J. Salipante, Daniel Sanghoon Shin, Eve Shinbrot, Brian H. Shirts, Sachet A. Shukla, Janet L. Stanford, Wei Sun, Jennifer Tsoi, Alexander Upfill‐Brown, David A. Wheeler, Catherine J. Wu, Ming Yu, Syed Hassan Ejaz Zaidi, Jesse M. Zaretsky, Stacey Gabriel, Eric S. Lander, Levi A. Garraway, Thomas J. Hudson, Charles S. Fuchs, Antoni Ribas, Shuji Ogino, Ulrike Peters - Cancer Discovery 2018 cited by 550

  17. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Giannakis, Shuji Ogino - Cancer Immunology Research 2018 cited by 226

  18. The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2020 cited by 236

  19. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease

    Authors: , , , , , , , , - Gut 2013 cited by 514

  20. Development and Validation of an Empirical Dietary Inflammatory Index

    Authors: , , , , , , , , - Journal of Nutrition 2016 cited by 470

  21. Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 159

  22. Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Giannakis, Shuji Ogino - Gastroenterology 2022 cited by 109

  23. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leona A. Doyle, Aaron R. Thorner, Matthew D. Ducar, Bruce M. Wollison, Angelica Laing, William C. Hahn, Matthew Meyerson, Charles S. Fuchs, Shuji Ogino, Jason L. Hornick, Aram F. Hezel, Albert C. Koong, Brian M. Wolpin - JAMA Oncology 2017 cited by 269

  24. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Per Pfeiffer, Naotoshi Sugimoto, Judit Kocsis, Andràs Csilla, G. Bodoky, Georgina Garnica Jaliffe, Светлана Проценко, Ayman Madi, Elżbieta Wójcik, Baruch Brenner, Gunnar Folprecht, Tomasz Sarosiek, Katriina Peltola, Peter Bono, Hubert Ayala, Giuseppe Aprile, Cardellino Giovanni Gerardo, Fidel David Huitzil Melendez, Alfredo Falcone, Francesco Di Costanzo, Moustapha Tehfe, Laurent Mineur, Pilar Alfonso, Radka Obermannová, Hélène Senellart, Russell Petty, Leslie Samuel, Péter Ács, Maen Hussein, M. Nechaeva, Frans Erdkamp, Elizabeth Won, Johanna C. Bendell, Javier Gállego, Sylvie Lorenzen, Bohuslav Melichar, Miguel Angel Escudero, Denis Pezet, Jean–Marc Phelip, Diego Kaen, James A. Reeves, Federico Longo Muñoz, Srinivasan Madhusudan, Carlo Barone, Luis Fein, Ángel Gómez Villanueva, Mohamed Hebbar, Jana Prausová, L. Visa Turmo, J. Vidal Barrull, Mette Yilmaz, Alex Beny, Hanneke W.M. van Laarhoven, Brian DiCarlo, Taito Esaki, Kazumasa Fujitani, Karen Geboes, Ravit Geva, Shigenori Kadowaki, Stephen Leong, Nozomu Machida, Moses S. Raj, Francisco Javier Ramírez Godinez, Ágnes Ruzsa, Hugo Ford, William Lawler, Nicolas Robert Maisey, Jiřı́ Petera, Einat Shacham‐Shmueli, Isabelle Sinapi and 44 more - The Lancet Oncology 2019 cited by 284